+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Registry Software Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • November 2023
  • Region: Global
  • Expert Market Research
  • ID: 5910820
The global cancer registry software market size was valued at USD 72.3 million in 2023, driven by rising healthcare digitization, increasing cancer prevalence, and government initiatives for cancer control across the globe. The market size is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032 to achieve a value of USD 175.8 million by 2032.

Cancer Registry Software: Introduction

Cancer Registry Software is a specialized tool designed to systematically collect, manage, and analyze data on cancer patients. This software plays a pivotal role in public health by capturing detailed information about cancer incidence, treatment, and outcomes. The data collected is crucial for cancer research, epidemiological studies, and public health interventions. It aids healthcare professionals and researchers in identifying patterns, trends, and risk factors associated with various types of cancer.

Furthermore, it assists hospitals and cancer treatment centres in patient management, treatment planning, and maintaining compliance with reporting requirements. Modern cancer registry software often features advanced functionalities such as data interoperability, user-friendly interfaces, robust data security, and compatibility with electronic health records (EHR) systems. This digital tool is instrumental in enhancing cancer surveillance, improving patient care, and ultimately contributing to efforts in cancer prevention and control.

Key Trends in the Global Cancer Registry Software Market

The global cancer registry software market was experiencing several key trends that were shaping its trajectory. Firstly, there was an increasing emphasis on digitalization and data integration, with a focus on interoperability between cancer registry software and electronic health records (EHRs), facilitating seamless data exchange and comprehensive patient care. The adoption of cloud-based solutions was on the rise, offering scalability, remote accessibility, and cost-effectiveness. Another notable trend was the integration of artificial intelligence (AI) and machine learning (ML) to enhance data analysis, enabling more accurate and efficient cancer surveillance and research. There was also a growing focus on patient-centric approaches, incorporating patient-reported outcomes and experiences into registries. The demand for real-time data analytics was escalating, driven by the need for timely insights for public health interventions and research.

Geographically, while developed regions like North America and Europe continued to lead the market, emerging economies were also witnessing significant growth, fuelled by increasing healthcare digitization and growing awareness of cancer control. However, challenges such as data privacy concerns, the need for skilled professionals, and disparities in healthcare infrastructure persisted. Overall, these trends indicated a dynamic market, reflecting the evolving landscape of cancer care and the critical role of registry software in it.

Global Cancer Registry Software Market Segmentation

Market Breakup by Software Type

  • Standalone
  • Integrated

Market Breakup by Database

  • Public Data
  • Commercial Data

Market Breakup by Deployment Type

  • Cloud-based
  • On-premise

Market Breakup by Functionality

  • Cancer Reporting
  • Patient Care
  • Medical Research

Market Breakup by End User

  • Government Organization
  • Hospital and Medical Practices
  • Research Centres and Private Payers
  • Pharmaceutical, Biotechnology and Medical Device Companies.
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Cancer Registry Software Market Overview

The global cancer registry software market was a crucial and expanding domain within healthcare IT, propelled by the growing need for efficient cancer data management and surveillance. North America was a leading market, underpinned by advanced healthcare infrastructure, strong government support for cancer research, and high adoption of digital health solutions. Europe also held a significant market share, characterized by robust healthcare systems and comprehensive cancer control programs. The Asia Pacific region was emerging as a fast-growing market, driven by rising healthcare digitization, increasing cancer prevalence, and government initiatives for cancer control. The market comprised a range of solutions, including patient registry software, healthcare data management systems, and analytics tools, with a trend towards cloud-based and AI-enhanced solutions.

Key players in the market were focusing on innovation, interoperability, and user-friendly designs to meet the evolving needs of healthcare professionals and researchers. Despite the growth, challenges such as data privacy concerns, the need for skilled IT professionals in healthcare, and disparities in access to advanced technology in certain regions persisted. Overall, the global Cancer Registry Software market was poised for continued growth, fuelled by the vital need for accurate and comprehensive cancer data to inform public health policies, research, and patient care.

Global Cancer Registry Software Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Centers for Disease Control and Prevention
  • IBM Corporation
  • Onco, Inc
  • Elekta AB (pub)
  • C/NET Solution
  • Ordinal Data, Inc
  • Conduent, Inc
  • himagine solutions
  • McKesson Corporation
  • IACR Official Website
  • F. Hoffmann-La Roche Ltd
  • NeuralFrame, Inc
  • IARC
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cancer Registry Software Market Overview
3.1 Global Cancer Registry Software Market Historical Value (2017-2023)
3.2 Global Cancer Registry Software Market Forecast Value (2024-2032)
4 Global Cancer Registry Software Market Landscape
4.1 Global Cancer Registry Software Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cancer Registry Software Product Landscape
4.2.1 Analysis by Software Type
4.2.2 Analysis by Database
4.2.3 Analysis by Deployment Type
4.2.4 Analysis by Functionality
5 Global Cancer Registry Software Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cancer Registry Software Market Segmentation
6.1 Global Cancer Registry Software Market by Software Type
6.1.1 Market Overview
6.1.2 Standalone
6.1.3 Integrated
6.2 Global Cancer Registry Software Market by Database
6.2.1 Market Overview
6.2.2 Public Data
6.2.3 Commercial Data
6.3 Global Cancer Registry Software Market by Deployment Type
6.3.1 Market Overview
6.3.2 Cloud-based
6.3.3 On-Premises
6.4 Global Cancer Registry Software Market by Functionality
6.4.1 Market Overview
6.4.2 Cancer Reporting
6.4.3 Patient Care
6.4.4 Medical Research
6.5 Global Cancer Registry Software Market by End User
6.5.1 Market Overview
6.5.2 Government Organization
6.5.3 Hospital and Medical Practices
6.5.4 Research Centres and Private Payers
6.5.5 Pharmaceutical, Biotechnology and Medical Device Companies
6.5.6 Others
6.6 Global Cancer Registry Software Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Cancer Registry Software Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cancer Registry Software Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cancer Registry Software Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cancer Registry Software Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cancer Registry Software Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding & Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Centers for Disease Control and Prevention
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 IBM Corporation
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Onco, Inc
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Elekta AB (pub)
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 C/NET Solution
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Ordinal Data, Inc
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Conduent, Inc
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 himagine solutions
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 McKesson Corporation
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 IACR Official Website
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 F. Hoffmann-La Roche Ltd
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 NeuralFrame, Inc
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 IARC
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
17 Global Cancer Registry Software Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • Centers for Disease Control and Prevention
  • IBM Corporation
  • Onco Inc
  • Elekta AB (pub)
  • C/NET Solution
  • Ordinal Data Inc
  • Conduent Inc
  • himagine solutions
  • McKesson Corporation
  • IACR Official Website
  • F. Hoffmann-La Roche Ltd
  • NeuralFrame Inc
  • IARC

Methodology

Loading
LOADING...